The challenge of bioprinting vascularized tissues is structure retention and in situ endothelialization. The issue is addressed by adopting an aqueous‐in‐aqueous 3D embedded bioprinting strategy, in which the interfacial coacervation… Click to show full abstract
The challenge of bioprinting vascularized tissues is structure retention and in situ endothelialization. The issue is addressed by adopting an aqueous‐in‐aqueous 3D embedded bioprinting strategy, in which the interfacial coacervation of the cyto‐mimic aqueous two‐phase systems (ATPS) are employed for maintaining the suspending liquid architectures, and serving as filamentous scaffolds for cell attachment and growth. By incorporating endothelial cells in the ink phase of ATPS, tubular lumens enclosed by coacervated complexes of polylysine (PLL) and oxidized bacteria celluloses (oxBC) can be cellularized with a confluent endothelial layer, without any help of adhesive peptides. By applying PLL/oxBC ATPS for embedded bioprinting, free‐form 3D vascular networks with in situ endothelialization of interconnected tubular lumens are achieved. This simple approach is a one‐step process without any sacrificed templates and post‐treatments. The resultant functional vessel networks with arbitrary complexity are suspended in liquid medium and can be conveniently handled, opening new routes for the in vitro production of thick vascularized tissues for pathological research, regeneration therapy and animal‐free drug development.
               
Click one of the above tabs to view related content.